EMRs are hospitals’ tech-of-choice for opioid management, KLAS finds

Most hospitals are leaning on EMRs to support their opioid management programs, according to a KLAS Research report.

Advertisement

KLAS Research polled more than 100 executives, directors and managers from hospitals and clinics for its report on popular strategies and technologies organizations are adopting for opioid management. Two-thirds of surveyed organizations labeled themselves as “novices” or “beginners” in terms of opioid stewardship.

EMRs were the most popular technology respondents said they used for various tasks related to opioid management, including identifying and preventing addiction at the point of care, identifying and monitoring problematic prescribing habits, identifying and monitoring possible drug diversion, and analyzing and directing care management efforts.

Most respondents were confident in EMR vendors’ ability to meet opioid stewardship expectations; however, they identified several aspects of the EMR that vendors could improve. Here are the top capabilities respondents cited they need from their EMR vendors to move their programs forward:

1. Prescription drug monitoring program or application programming interface integration: 41 percent

2. Opioid-specific clinical decision support or tool sets: 34 percent

3. Population health management for opioid use disorder: 12 percent

4. Prescriber monitoring: 5 percent

Nine respondents said they were unsure and four respondents cited “other.”

To download KLAS Research’s report, click here.

More articles on opioids:
White House rolls out 2nd opioid ad as part of public awareness campaign
Melania Trump tours Philadelphia hospital’s NICU, speaks on neonatal abstinence syndrome
48% of hospitals see patients with drug-seeking behavior daily, survey finds

Advertisement

Next Up in Uncategorized

  • Health systems are navigating a rapidly evolving healthcare environment where patient safety is shaped by both longstanding challenges and emerging…

  • Since 2020, CHS has announced or completed the sale of 35 hospitals:  2025 2024 2023 2022 2021 In July 2021,…

  • Sacroiliac joint fusion technology is advancing, and the data shows it’s efficacy across different medtech companies. Five notes: 1. Tenon…

Advertisement

Comments are closed.